XACT ACE Observational Registry

Conditions

• Tumors

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T — DEVICE
  The system is used for trajectory planning and is intended to assist the physician in the positioning of an instrument, such as a needle, where CT imaging is used for target trajectory planning and intraoperative tracking. The XACT ACE Robotic System uses a computerized quantitative guidance system, which provides real-time, accurate needle guidance, including advancement and steering of the needle from the entry point on the subject's body to the target point within the body.

Study Details

Compile real world data on the use of the XACT ACE Robotic System

Key Dates

Start date

Oct 1, 2021

Status verified

Oct 2022

Primary completion

Jul 1, 2026

Completion

Aug 1, 2026

Study Design

Enrollment

500 participants (estimated)

Arms

• Arm: All subjects
  Subjects undergoing CT-guided, minimally invasive percutaneous procedures in an interventional radiology setting

Primary Outcome Measure

Proportion of successful procedures [ Time Frame: 1 hour ]

Central Contacts

• Mark Macedo
  5082076505
  [email protected]

Locations (1)

Find similar trials in Burlington, MA

Related Studies

• HP Pyruvate MRI in Cancers
  PHASE1/PHASE2 · Recruiting · University of Maryland, Baltimore · Baltimore, Maryland
• Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
  Recruiting · M.D. Anderson Cancer Center · Houston, Texas